First sickle cell drug approved in two decades

The FDA approved the first new treatment for sickle cell disease in nearly 20 years. The new drug, Endari, (L-glutamine oral powder) was studied in a randomised placebo controlled trial of patients ages five to 58 years old with sickle cell disease who had two or more painful crises within the 12 months prior to enrollment ...

Already a member?

Login to keep reading.

© 2021 the limbic